Dr. Krishna Prasad Chigurupati, a promoter of Granules India Limited, has divested 1,72,00,000 equity shares through a block deal on September 11, 2026. This transaction represents 6.94% of the company’s total diluted share capital. The sale involved marquee institutional investors, including Capital Group and Kotak Mahindra Life Insurance, among others.
Significant Promoter Share Sale at Granules India
A substantial transaction has taken place involving Dr. Krishna Prasad Chigurupati, a key promoter of Granules India Limited. On September 11, 2026, Dr. Chigurupati sold a total of 1,72,00,000 equity shares of the company through an off-market block deal. This sale represents a significant portion of his holding, amounting to 6.94% of the total diluted share capital of Granules India.
Transaction Details and Participants
The block deal involved the transfer of shares from the promoter to a consortium of prominent investors. The transaction saw the participation of several marquee institutional investors, including Capital Group, Kotak Mahindra Life Insurance Company, ChrysCapital, and Allspring, alongside other domestic and global investors. This indicates a strong interest from institutional players in Granules India’s equity.
Impact on Shareholding
Prior to this sale, Dr. Krishna Prasad Chigurupati held 7,68,08,111 equity shares, representing 31.00% of the total capital. Following the sale of 1,72,00,000 shares, his direct holding has reduced to 5,96,08,111 equity shares, now constituting 24.06% of the total diluted share capital. The total voting rights also adjusted accordingly, from 31.00% before the sale to 24.06% after the sale.
Company Capital Structure
The equity share capital of Granules India Limited remained unchanged at Rs. 24,77,96,921/- (24,77,96,921 equity shares of Re. 1/- each) before the said acquisition/sale. However, the total diluted share/voting capital of the company increased to Rs. 27,27,96,921/- (27,27,96,921 equity shares of Re. 1/- each) after the transaction, reflecting the adjustments in outstanding shareable instruments or dilution from other factors, though the primary transaction was an equity share sale.
Source: BSE
